Aster will be investing around Rs. 140 crores on the proposed tertiary care hospital which will be situated in the Kasaragod district of Kerala, catering to patients from Malabar and Southern Karnataka. Aster aims to begin its operations at the new hospital in FY25.

A total of 8,209 cases of the Omicron variant have been detected across 29 states and union territories, out of which 3,109 have recovered or migrated. Maharashtra recorded the maximum 1,738 cases of the Omicron variant, followed by West Bengal 1,672, Rajasthan 1,276, Delhi 549, Karnataka 548 and Kerala 536 cases.

The ruling came in response to an application by Divyajivan Healthcare LPP. It had approached the AAR seeking clarity on levy of GST on a membership plan in its proposed multi-super specialty hospital.

In the weekly report issued Tuesday night, the U.N. health agency said there were about 15 million new COVID-19 cases last week and more than 43,000 deaths. Every world region reported a rise in COVID-19 cases except for Africa, where officials saw an 11% drop.

In a joint statement on Tuesday, BioNTech and its partner said the new computational method can analyse genetic sequencing data of new coronavirus mutations found in infected people and assesses the risk they pose within days and sometimes within just minutes.

Pfizer has entered into advance purchase agreements with multiple countries. Sources told ET that Pfizer is yet to apply for emergency use authorisation in India.

The full treatment of Molulife (brand name) is expected to cost 1,400, RC Juneja, chairman of Mankind Pharma, told ET. The brand is expected to hit this week in the market, he said.

Mr. Reddy has been a key member of Aurobindo leadership and has played a pivotal role in the Companys growth journey since inception. A veteran of the pharma industry, he has expertise in manufacturing technology and has been actively involved in the overall affairs and the strategic decision making of the Company, Aurobindo said in a regulatory filing.

Bangladesh's directorate general of drug administration on Thursday granted emergency use authorisation for the oral antiviral drug to treat mild-to-moderate Covid-19 in adults and children of 12 years and above.

Last month Pfizer had announced an agreement with the UN's Medicines Patent Pool (MPP) for licensing antiviral intellectual property to MPP with the goal of making the drug available in low and middle-income countries.

The recommended dose of molnupiravir is 800 mg twice a day for five days. With companies planning to launch 200 mg capsules, a patient will need to swallow 40 of them during the course of the treatment.

Drug maker Cipla said it will soon make molnupiravir capsules available at all leading pharmacies and Covid treatment centers across the country. The Drug Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation(EUA) permission for the launch of molnupiravir in the country.

The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) reviewed the emergency use authorisation (EUA) application for the second time on Monday and after detailed deliberation recommended granting emergency use authorisation to Covovax, an official source said.

Three private equity led investment platforms have been created specifically targeting the API space, while at least half a dozen transactions are in various stages of negotiations, according to bankers and fund managers.